Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 protease | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | intracisternal A-particle retropepsin (A02 family) | Get druggable targets OG5_131408 | All targets in OG5_131408 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | BC026374 protein (S09 family) | 0.036 | 0.0442 | 0.0442 |
Loa Loa (eye worm) | hypothetical protein | 0.036 | 0.0442 | 0.0312 |
Echinococcus granulosus | acetylcholinesterase | 0.2128 | 1 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.2128 | 1 | 1 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.2128 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.036 | 0.0442 | 0.0312 |
Brugia malayi | Carboxylesterase family protein | 0.2128 | 1 | 1 |
Onchocerca volvulus | 0.036 | 0.0442 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.036 | 0.0442 | 0.0312 |
Onchocerca volvulus | 0.036 | 0.0442 | 0.5 | |
Echinococcus granulosus | acetylcholinesterase | 0.2128 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.036 | 0.0442 | 0.0442 |
Loa Loa (eye worm) | carboxylesterase | 0.2128 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.036 | 0.0442 | 0.0312 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.0518 | 0.1298 | 0.1298 |
Schistosoma mansoni | acetylcholinesterase | 0.036 | 0.0442 | 0.0442 |
Onchocerca volvulus | 0.036 | 0.0442 | 0.5 | |
Mycobacterium ulcerans | carboxylesterase, LipT | 0.036 | 0.0442 | 0.5 |
Onchocerca volvulus | 0.036 | 0.0442 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.036 | 0.0442 | 0.0312 |
Echinococcus granulosus | carboxylesterase 5A | 0.2128 | 1 | 1 |
Trichomonas vaginalis | spcc417.12 protein, putative | 0.036 | 0.0442 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0563 | 0.1542 | 0.1428 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.036 | 0.0442 | 0.0442 |
Onchocerca volvulus | 0.036 | 0.0442 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.2128 | 1 | 1 |
Mycobacterium tuberculosis | Carboxylesterase LipT | 0.036 | 0.0442 | 0.5 |
Loa Loa (eye worm) | carboxylesterase | 0.036 | 0.0442 | 0.0312 |
Schistosoma mansoni | neuroligin 3 (S09 family) | 0.036 | 0.0442 | 0.0442 |
Echinococcus multilocularis | acetylcholinesterase | 0.2128 | 1 | 1 |
Echinococcus multilocularis | carboxylesterase 5A | 0.2128 | 1 | 1 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.2128 | 1 | 1 |
Schistosoma mansoni | gliotactin | 0.036 | 0.0442 | 0.0442 |
Loa Loa (eye worm) | hypothetical protein | 0.036 | 0.0442 | 0.0312 |
Brugia malayi | Amyloid A4 extracellular domain containing protein | 0.0715 | 0.2361 | 0.2008 |
Loa Loa (eye worm) | hypothetical protein | 0.036 | 0.0442 | 0.0312 |
Loa Loa (eye worm) | carboxylesterase | 0.036 | 0.0442 | 0.0312 |
Loa Loa (eye worm) | hypothetical protein | 0.2128 | 1 | 1 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.036 | 0.0442 | 0.5 |
Schistosoma mansoni | intracisternal A-particle retropepsin (A02 family) | 0.1528 | 0.6756 | 0.6756 |
Mycobacterium tuberculosis | POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) | 0.036 | 0.0442 | 0.5 |
Trichomonas vaginalis | carboxylesterase domain containing protein, putative | 0.036 | 0.0442 | 0.5 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.036 | 0.0442 | 0.0442 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 1400 nM | Antiviral activity against HIV-1, IIIB, in MT-4 Cells | ChEMBL. | 8642565 |
Ki (binding) | = 15 nM | Binding affinity against HIV-1 protease | ChEMBL. | 8642565 |
Ki (binding) | = 15 nM | Binding affinity against HIV-1 protease | ChEMBL. | 8642565 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.